Clinical Trial: Sodium Hyaluronate Injection and Corticosteroids in Trochanteric Bursitis: a Randomized Controlled Study.
Study Status: Withdrawn
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Sodium Hyaluronate Injection and Corticosteroids in Trochanteric Bursitis: a Randomized Controlled Study.
Brief Summary:
Trochanteric pain can be caused by osteoarthritis of the hip, fracture, tendinitis, nerve pathology and trochanteric bursitis. Trochanteric bursitis is often seen at the outpatient clinic and is characterized by chronic lateral hip pain in the vicinity of the trochanter major, overlying the lateral aspect of the hip. When pain is persistent after conventional therapies, anesthetic and corticosteroid (CS) injections can provide short term to intermediate relief of pain, but relapse is common. Only one retrospective study showed the efficacy of intra-bursal trochanteric injections with HA and CS. They concluded that the pain release is significant with large effect sizes for both treatment. However, the efficacy of CS appeared to be short lived and it was shown that the efficacy of HA at 6 and 12 months is significant compared to CS (p<0.05).
In this study we want to compare the efficacy of corticosteroids and hyaluronic acid in the treatment of trochanteric bursitis.
Detailed Summary: See brief summary
Sponsor: Universitaire Ziekenhuizen Leuven
Current Primary Outcome: VAS for pain [ Time Frame: 26 weeks after administration ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Harris Hip Score [ Time Frame: 6, 12, 26 weeks ]
- VAS for pain [ Time Frame: 6 and 12 weeks after administration ]
Original Secondary Outcome: Same as current
Information By: Universitaire Ziekenhuizen Leuven
Dates:
Date Received: July 24, 2013
Date Started: March 2014
Date Completion: December 2015
Last Updated: March 25, 2014
Last Verified: March 2014
